“Do any of us have any authority? God no. But we can bring the right people into the room who have the authority and responsibility in their own domains," said Martin Murphy, head of the CEO Roundtable on Cancer.
Old and new research worlds collided on Thursday through the partnership of the decades-old Cancer Research Institute (CRI) and The Parker Institute for Cancer Immunotherapy, created by tech billionaire Sean Parker in April 2016.
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.